For the Inventor, By the Inventor

Enter assignee name

Agoura Hills, CA, United States of America

A2 Biotherapeutics, Inc.

USPTO Granted Patents = 16

EPO Patents = 1

Trademarks = 1

Forward Citations = 11

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Carl Alexander Kamb (10 out of 10 patents)

Agnes Eva Hamburger (6 out of 36 patents)

Alexander Kamb (6 out of 6 patents)

4. Breanna Diandreth (4 out of 4 patents)

5. Mark E Daris (4 out of 8 patents)

6. Kiran Deshmukh (4 out of 4 patents)

7. Han Xu (4 out of 4 patents)

8. Dora Toledo Warshaviak (3 out of 3 patents)

9. Xueyin Wang (2 out of 2 patents)

10. Mark L Sandberg (2 out of 2 patents)

11. Julyun Oh (2 out of 2 patents)

12. Talar Tokatlian (1 out of 1 patent)

13. Yuta Ando (1 out of 1 patent)

14. Jee Young Mock (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 12599665 - GENE FUSIONS FOR CONTROL OF GENETICALLY MODIFIED CELLS (2026-04-14),

2. 12595291 - ENGINEERED IMMUNE CELLS WITH MICRO-CLUSTERS (2026-04-07),

3. 12534509 - ENGINEERED IMMUNE CELLS WITH RECEPTOR CROSS-TALK (2026-01-27),

4. 12459983 - Engineered immune cells with receptor signal strength modulated by a hinge (2025-11-04),

5. 12435124 - Compositions and methods for treating CEACAM positive cancers (2025-10-07),

6. 12215134 - Engineered immune cells with dominant signals (2025-02-04),

7. 12195513 - LILRB1-based chimeric antigen receptor (2025-01-14),

8. 12187775 - LILRB1-based chimeric antigen receptor (2025-01-07),

9. 12037377 - LILRB1-based chimeric antigen receptor (2024-07-16),

10. 12012612 - Engineered immune cells with receptor signal strength modulated by a hinge (2024-06-18),

11. 11976297 - Engineered immune cells with receptor cross-talk (2024-05-07),

12. 11730764 - Compositions and methods for treating HER2 positive cancers (2023-08-22),

13. 11602544 - Compositions and methods for treating EGFR positive cancers (2023-03-14),

14. 11602543 - Compositions and methods for treating mesothelin positive cancers (2023-03-14),

15. 11433100 - Compositions and methods for treating ceacam positive cancers (2022-09-06),

A2 Biotherapeutics, Inc. is a biotechnology company based in Agoura Hills, California, focused on developing innovative cell therapies for cancer treatment. The company specializes in engineering T cells to target and eliminate tumors while minimizing damage to healthy tissues. A2 Biotherapeutics leverages advanced technologies in immunotherapy and genetic engineering to create therapies that aim to improve patient outcomes in oncology. Their research is dedicated to addressing unmet medical needs in cancer care through precision medicine.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#4 in Agoura Hills, CA

#4,767 in California

#19,907 in US

#37,788 in the World

Agoura Hills, CA, United States of America

A2 Biotherapeutics, Inc.

Forward Citations = 11

14 inventors:

Carl Alexander Kamb (10 out of 10 patents)

Agnes Eva Hamburger (6 out of 36 patents)

Alexander Kamb (6 out of 6 patents)

4. Breanna Diandreth (4 out of 4 patents)

5. Mark E Daris (4 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…